Gary P. Anderson (Parkville, Australia), Jonas Erjefalt (Lund, Sweden)
Time course of serum inhibitory activity for facilitated allergen-IgE binding during house dust mite immunotherapy
Jing Li (Guangzhou, China), Mulin Feng, Zhaowei Yang, Jing Li
|   |
IL-13 induces glucocorticoid-insensitive hyperreactivity of human small airways
Anna James (Stockholm, Sweden), Martijn Manson, Anna James, Jesper Säfholm, Mamdoh Al-Ameri, Per Bergman, Ann-Charlotte Orre, Sven-Erik Dahlén, Mikael Adner
| |
Tiotropium Respimat® add-on therapy in children with symptomatic asthma
Christian Vogelberg (Dresden, Germany), Christian Vogelberg, Petra Moroni-Zentgraf, Migle Leonaviciute-Klimantaviciene, Ralf Sigmund, Eckard Hamelmann, Michael Engel, Stanley Szefler
| |
IL-17A is specifically elevated in NTHi-associated AECOPD and end-stage COPD
Abraham Roos (Hamilton, Canada), Abraham Roos, Sanjay Sethi, Leif Bjermer, Christopher Stevenson, Jonas Erjefalt, Martin Stampfli
| |
Efficacy of tiotropium Respimat® in adults with moderate asthma, by baseline LTRA use
Ronald Dahl (Odense C, Denmark), Ronald Dahl, Thomas Casale, Eugene Bleecker, Emilio Pizzichini, Michael Engel, Petra Moroni-Zentgraf, Louis Bour, Huib Kerstjens
| |
Ultra-rush sublingual immunotherapy: Safety of use for patients with various allergic manifestations
Zied Moatemri (Ariana, Tunisia), Zied Moatemri, Nidhal Belloumi, Salsabil Dabboussi, Samira Mhamdi, Abir Hedhli, Chiraz Aichaouia, Mohsen Khadraoui, Rezaik Cheikh
| |
BioPhysical bronchodilator: A new class of respiratory drug
John Dennis (Calgary, Canada), John Dennis, Richard Leigh, Tamer ElMays, Francis Green
| |
Aspergillus fumigatus sensitization in COPD and smokers
Stéphanie Everaerts (Leuven, Belgium), Stephanie Everaerts, Erna Van Hoeyveld, Kristina Vermeersch, Lieven Dupont, Bart Vanaudenaerde, Xavier Bossuyt, Katrien Lagrou, Wim Janssens
| |
The utility of HLA-DQB302 as a genetic marker to predict the effect of aspirin desensitization on lung function of patients with aspirin exacerbated respiratory disease
Zahra Aryan (Tehran, Islamic Republic of Iran), Zahra Aryan, Hossein Esmaeilzadeh, Ali Akbar Amirzargar, Mohammad Nabavi
| |
Differentiate late-onset asthma and COPD by CD4+ T memory cells in peripheral blood
Zhihong Chen (Shanghai, China), Zhihong Chen, Kan Xu, Xinjun Tang, Zhihui Min, Xiangdog Wang
| |
Periostin and TSLP: New markers useful in diagnosis of obstructive lung disease
Patrycja Nejman-Gryz (Warsaw, Poland), Patrycja Nejman-Gryz, Katarzyna Górska, Magdalena Paplinska-Goryca, Malgorzata Proboszcz
| |
Upregulation of the high-affinity IgE receptor on plasmacytoid dendritic cells in severe COPD
Paul Stoll (Rostock, Germany), Paul Stoll, Anne Baehker, Martin Ulrich, Kai Bratke, Katharina Garbe, J. Christian Virchow, Marek Lommatzsch
| |
Differences in systemic immune function contribute to exacerbation susceptibility in COPD patients
Jasper Geerdink (Nijmegen, Netherlands), Jasper Geerdink, Sami Simons, Rebecca Pike, Jadwiga Wedzicha, Hans Stauss, Yvonne Heijdra, John Hurst
| |
Diagnostic implications of sTREM-1 in induced sputum and BAL fluid of patients with asthma and COPD
Małgorzata Proboszcz (Kielce, Poland), Malgorzata Proboszcz, Katarzyna Górska, Magdalena Paplinska-Goryca, Patrycja Nejman-Gryz
| |
Increased circulating alveolar epithelial microparticles in COPD patients
Toru Takahashi (Montreal, Canada), Toru Takahashi, Mitsuhiro Yamada, Seiichi Kobayashi, Tomonori Makiguchi, Chiharu Ota, Hiroshi Kubo
| |
Risk factors for frequent exacerbations in (ex)smoking and never-smoking adult-onset asthma patients
Guus Westerhof (Amsterdam, Netherlands), Guus Westerhof, Christa De Groot, Marijke Amelink, Selma De Nijs, Els Weersink, Anneke Ten Brinke, Elisabeth Bel
| |
Evaluation of protease-antiprotease imbalance in moderate COPD without antitrypsin deficiency
Charanjeet Kaur (New Delhi, India), Charanjeet Kaur, Balakrishnan Menon, Mohammad Yusuf Dar, Harsh Vardhan
| |